We are halfway through the year, and it's time to take a look back at some of the regulatory news that made headlines in June and look ahead to what lies in store for the biotech stocks at the FDA altar.
from RTT - Biotech https://ift.tt/2lGcU7F
via IFTTT
No comments:
Post a Comment